Pressreleases

Wilson Therapeutics reports highly successful Phase II study

Chemoswed was selected as active ingredient supplier by Wilson Therapeutics as they began developent of WTX101 for the treatment of Wilson’s disease.

Almac Group Launches Next Generation Temperature Management Software

Innovative ‘TempEZ™’ solution offers unrivalled end-to-end drug product visibility

Almac Group Announces Further Global Expansion as it Secures New Premises in Republic of Ireland

Craigavon based global contract pharmaceutical development and manufacturing organisation, Almac Group, has secured new premises in Dundalk, County Louth to support its ongoing global expansion plans in response to increased client demand.

Paralysed by Complexity? Solutions that Work

Over-complexity is the silent killer for many companies, and it’s a proven fact. The largest 200 companies in the Global Fortune 500 listing lose approximately 10.2% of shareholder value every year due to complexity

Johnson Matthey Launches New Online Catalyst Store

West Deptford, N.J. – 11 January 2017, Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, is pleased to announce the launch of its new online catalyst store

Introducing Morphologically-Directed Raman Spectroscopy

A powerful tool for the detection of counterfeit drugs

Time to Harness the True Power of Rheology

Upgrading from a viscometer to a modern rotational rheometer brings access to a range of test methods that can be applied to accelerate and enhance the formulation of personal care products

Almac Group Launches Almac Clinical University

A first-in-industry, web-based training & education platform designed to enhance, educate, and strengthen connections with valued clients and industry professionals across the globe.

LTS to Present at JP Morgan 35th Annual Healthcare Conference

LTS has announced that its CMO Dr Tim G Schlange will present at the JP Morgan 35th Annual Healthcare Conference.